showed that miR‐137, which can target the 3′ UTR of MSH2, is able to reversely regulate its expression in colorectal cancer, and dysregulation of the process may play a role in promoting the development of Lynch syndrome‐related tumors [37]. The gene discussed is MSH2; the disease is colorectal cancer.